Literature DB >> 17432822

Novel inositol phospholipid headgroup surrogate crystallized in the pleckstrin homology domain of protein kinase Balpha.

Stephen J Mills, David Komander, Melanie N Trusselle, Stephen T Safrany, Daan M F van Aalten, Barry V L Potter.   

Abstract

Protein kinase B (PKB/Akt) plays a key role in cell signaling. The PH domain of PKB binds phosphatidylinositol 3,4,5-trisphosphate translocating PKB to the plasma membrane for activation by 3-phosphoinositide-dependent protein kinase 1. The crystal structure of the headgroup inositol 1,3,4,5-tetrakisphosphate Ins(1,3,4,5)P4-PKB complex facilitates in silico ligand design. The novel achiral analogue benzene 1,2,3,4-tetrakisphosphate (Bz(1,2,3,4)P4) possesses phosphate regiochemistry different from that of Ins(1,3,4,5)P4 and surprisingly binds with similar affinity as the natural headgroup. Bz(1,2,3,4)P4 co-crystallizes with the PKBalpha PH domain in a fashion also predictable in silico. The 2-phosphate of Bz(1,2,3,4)P4 does not interact with any residue, and the D5-phosphate of Ins(1,3,4,5)P4 is not mimicked by Bz(1,2,3,4)P4. Bz(1,2,3,4)P4 is an example of a simple inositol phosphate surrogate crystallized in a protein, and this approach could be applied to design modulators of inositol polyphosphate binding proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17432822     DOI: 10.1021/cb700019r

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  9 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

Review 2.  Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain.

Authors:  E J Meuillet
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Benzene polyphosphates as tools for cell signalling: inhibition of inositol 1,4,5-trisphosphate 5-phosphatase and interaction with the PH domain of protein kinase Balpha.

Authors:  Stephen J Mills; Fabrice Vandeput; Melanie N Trusselle; Stephen T Safrany; Christophe Erneux; Barry V L Potter
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

4.  Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.

Authors:  Lei Du-Cuny; Zuohe Song; Sylvestor Moses; Garth Powis; Eugene A Mash; Emmanuelle J Meuillet; Shuxing Zhang
Journal:  Bioorg Med Chem       Date:  2009-08-19       Impact factor: 3.641

5.  A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery.

Authors:  Stephen J Mills; Camilla Persson; Gyles Cozier; Mark P Thomas; Lionel Trésaugues; Christophe Erneux; Andrew M Riley; Pär Nordlund; Barry V L Potter
Journal:  ACS Chem Biol       Date:  2012-02-27       Impact factor: 5.100

6.  Insights into the activation mechanism of class I HDAC complexes by inositol phosphates.

Authors:  Peter J Watson; Christopher J Millard; Andrew M Riley; Naomi S Robertson; Lyndsey C Wright; Himali Y Godage; Shaun M Cowley; Andrew G Jamieson; Barry V L Potter; John W R Schwabe
Journal:  Nat Commun       Date:  2016-04-25       Impact factor: 14.919

7.  Crystal Structures of Type-II Inositol Polyphosphate 5-Phosphatase INPP5B with Synthetic Inositol Polyphosphate Surrogates Reveal New Mechanistic Insights for the Inositol 5-Phosphatase Family.

Authors:  Stephen J Mills; Camilla Silvander; Gyles Cozier; Lionel Trésaugues; Pär Nordlund; Barry V L Potter
Journal:  Biochemistry       Date:  2016-02-29       Impact factor: 3.162

8.  Regioisomeric Family of Novel Fluorescent Substrates for SHIP2.

Authors:  Gaye White; Christopher Prior; Stephen J Mills; Kendall Baker; Hayley Whitfield; Andrew M Riley; Vasily S Oganesyan; Barry V L Potter; Charles A Brearley
Journal:  ACS Med Chem Lett       Date:  2019-10-18       Impact factor: 4.345

9.  A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate.

Authors:  M Falasca; D Chiozzotto; H Y Godage; M Mazzoletti; A M Riley; S Previdi; B V L Potter; M Broggini; T Maffucci
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.